| Topic: | Diabetes (DM) |
| Title: | Pharmacologic Therapies for Glucose Management. |
| Author: | White, J.R.; Campbell, R.K. |
| Source: | In: Franz, M.J., et al., eds. Core Curriculum for Diabetes Education. 5th ed. (Volume 2) Diabetes Management Therapies. Chicago, IL: American Association of Diabetes Educators (AADE). 2003. p. 93-154. |
| Availability: | Available from American Association of Diabetes Educators (AADE). AADE Member Service Center, 100 W. Monroe Street, Suite 400, Chicago, IL 60603. (800) 338-3633 or (312) 424-2426. Fax (312) 424-2427. Email: products@aadenet.org. Website: www.aadenet.org. PRICE: Individual volume $55.00 for members and $75.00 for nonmembers: complete 4-volume set $159.95 for members and $229.95 for nonmembers; plus shipping and handling. ISBN: 881876128 (Volume 2); 881876152 (4-volume set). |
| Abstract: | For the majority of people with diabetes, their treatment includes pharmacologic (drug) intervention. In addition to oral medications or insulin, the pharmacologic therapies for a person with diabetes often include other agents to treat the myriad of associated comorbid conditions or complications of diabetes. This chapter on pharmacologic therapies for glucose management for diabetes is from a handbook of the CORE Curriculum, a publication that helps educators prepare for the Certified Diabetes Educators (CDE) exam, serves as a key reference for the Advanced Diabetes Management credential exam, and provides an authoritative source of information for diabetes education, training, and management. This chapter covers the physiologic effects of insulin; the different types of insulin preparations based upon species, source, type, purity, and concentration; proper administration and storage of insulin; the limitations of insulin mixing; the similarities and differences of potential insulin therapy regimens, including the use of insulin pumps, and indications for specific insulin products; commonly encountered insulin regimens in people with type 1 and type 2 diabetes; the differences between use of insulin in a person with type 1 and type 2 diabetes; the mechanisms of action of sulfonylureas, d-phenylalanine derivatives, meglitinides, biguanides, alpha-glucosidase inhibitors, and thiazolidinediones; the clinical use of these drug families; the use of combination therapy in people with type 2 diabetes; the clinical use of glucagon; and potential drug-disease, drug-drug, and drug-food interactions. The chapter includes an introduction, a list of learning objectives, key definitions (glossary), key educational considerations, self review questions, references, and a post-test (including an answer key). 8 figures. 9 tables. 84 references. |
| Format: | Book Chapter |
| Language: | English. |
| Major Keywords: | Diabetes Mellitus. Patient Care Management. Drug Therapy. Guidelines. Drug Effects. Oral Hypoglycemic Agents. Insulin. Type 1 Diabetes. Type 2 Diabetes. |
| Minor Keywords: | Administration and Dosage. Antidiabetic Agents. Pharmacology. Glucagon. Monitoring. Blood Glucose. Hyperglycemia. Complications. Biguanides. Sulfonylurea Compounds. Thiazolidinediones. Alpha Glucosidase Inhibitors. Meglitinides. |
| Publication Number: | DMBK11509 |
| Return to Search Results | |